Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? (vol 16, e1008421, 2019)

被引：2
|
作者：
Liu, Ping
Jiang, Jing-Zhe
Wan, Xiu-Feng
Hua, Yan
Li, Linmiao
Zhou, Jiabin
Wang, Xiaohu
Hou, Fanghui
Chen, Jing
Zou, Jiejian
Chen, Jinping
机构：
来源：
PLOS PATHOGENS | 2021年 / 17卷 / 06期
关键词：
D O I：
10.1371/journal.ppat.1009664
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Rate and predictive parameters of novel Coronavirus 2019 (Sars-CoV-2) infections in a German General Practice
    Moritz Paar
    Christoph Strumann
    Heinz Giesen
    Irish Journal of Medical Science (1971 -), 2022, 191 : 31 - 37
  • [32] Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
    Zhou, Yadi
    Hou, Yuan
    Shen, Jiayu
    Huang, Yin
    Martin, William
    Cheng, Feixiong
    CELL DISCOVERY, 2020, 6 (01)
  • [33] Rate and predictive parameters of novel Coronavirus 2019 (Sars-CoV-2) infections in a German General Practice
    Paar, Moritz
    Strumann, Christoph
    Giesen, Heinz
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (01) : 31 - 37
  • [34] Analysis of SARS-CoV-2 in Corneal Tissue of Deceased Asymptomatic Novel Coronavirus Disease 2019 Donors
    Mahalingam, Karthikeyan
    Angmo, Dewang
    Kakkar, Aanchal
    Bafna, Rahul Kumar
    Sharma, Tushar
    Rai, Aishwarya
    Agrawal, Sahil
    Dar, Lalit
    Saxena, Rohit
    Titiyal, Jeewan S.
    Sharma, Namrata
    CORNEA, 2022, 41 (12) : 1559 - 1563
  • [35] A Case Series of the 2019 Novel Coronavirus (SARS-CoV-2) in 3 Febrile Infants in New York
    Feld, Lance
    Belfer, Joshua
    Kabra, Rashi
    Goenka, Pratichi
    Rai, Shipra
    Moriarty, Shannon
    Barone, Stephen
    PEDIATRICS, 2020, 146 (01)
  • [36] Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus(SARS-CoV-2)
    Chang-quan Ling
    JournalofIntegrativeMedicine, 2020, 18 (02) : 87 - 88
  • [37] Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)
    Ling, Chang-quan
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2020, 18 (02): : 87 - 88
  • [38] Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
    Yadi Zhou
    Yuan Hou
    Jiayu Shen
    Yin Huang
    William Martin
    Feixiong Cheng
    Cell Discovery, 6
  • [39] Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
    Kumar S.
    Maurya V.K.
    Prasad A.K.
    Bhatt M.L.B.
    Saxena S.K.
    VirusDisease, 2020, 31 (1) : 13 - 21
  • [40] SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
    Rabi, Firas A.
    Al Zoubi, Mazhar S.
    Kasasbeh, Ghena A.
    Salameh, Dunia M.
    Al-Nasser, Amjad D.
    PATHOGENS, 2020, 9 (03):
12345